This advisory summarizes data on the use of sublingual and transmucosal buprenorphine for the medication-assisted treatment of opioid use disorder.
Dashboard: Filter Bricks
Main page content
Displaying results 1 - 1 of 1
Publication ID: SMA16-4938
Published: